Project Manager Data

KOTESWARA R. CHINTALACHARUVU, PhD

**** ******* ****** ********, ********** 90503

Contact Info: 310-***-**** ******@*****.***

CV at LinkedIn: www.linkedin.com/in/koteswara-chintalacharuvu-6961a846?trk=hp-identity-photo

SUMMARY

Data scientist with experience in directing Statistical Modeling in Data Science, Spark, and Hadoop. Led the development of analytical models to forecast Residual Value, Elasticity of Incentives, Elasticity of MSRP and forecast metrics to estimate General Increase of MSRP of motor vehicles based on historical data. These models are in use by the customer, one of the biggest motor vehicle corporation in USA and the world. Looking to apply my knowledge in Machine Learning algorithms. Scientist adept at solving complex problems in concepts and technology development. Has 20 years of management experience obtaining funding for projects, supervising and mentoring staff and students.

SOFTWARE ENGINEERING and DATA SCIENCE SKILLS

Technical lead with management skills in all aspects of software development including analytical model designing, producing design documents, reviewing code functionality, unit testing and QA testing with data validation and deployment/production

Expertise in R programing, Statistical modeling, Data Analysis and Visualization

Experience in Hadoop, Spark and Scala

Application of Machine Learning algorithms: Linear Regression and Classification Regression

SEE ML Scala code example at http://kotec1.wixsite.com/krctek

Knowledge of C, Python, Scala, SQL and Tableau

Refining of the format of data from third party sources as required for use by the models

Develop documentation for standard operating procedures

Effective communication skills

PROFESSIONAL EXPERIENCE

Senior Data Scientist, KaizenAnalytix, Inc. & Toyota Motor Sales HQ 12/2015 – 04/2017

Architect and supervisor of six analytical models. Currently, Toyota is using 4 models online,

and two models are being tested.

Achievements

Generated technical design documents to convince the customers that the projects were feasible and to provide a framework for coding the application

Developed R code in the HTTR framework to generate statistical formulas and validate results

Coded statistical methods not available in Java to save time and effort for the coders

Managed coding of 4 models in Java and 2 models in Scala

Managed historical data validation from 20 external vendors

Managed testing of the models and validated the results against existing market data

Managed the application coders and testers so they felt like partners in delivering the product on time

Director, Data Science, Analytics, Biotechnology, Viewics, Inc. 5/2015 – 11/2015

Designed software to analyze DNA sequencing data and to correlate gene mutations with diseases

Research Scientist & Biologist, Veterans Administration, Los Angeles, CA 4/2014 – 4/2015

Developed computer models to produce novel amphotericin B drugs to deliver across the BBB for treatment of fungal and bacterial infections. Based on the computer models, synthesized drugs and injected into small animals with fungal meningitis. Produced drugs that increased survival.

Research Scientist at the Human Brain and Spinal Fluid Resource Center 5/2013 – 3/2014

Analyzed human tissue in the brain bank and setup a database describing the quality of the frozen tissue.

Achievements

Setup database to include the frozen tissue using patient ID making this one of the biggest brain bank databases in the country

Successfully developed database with field names pH, RNA stability & the presence of viruses in the postmortem brain tissue from 3000 individuals with CNS diseases

Set up a database containing ELISA data for the presence of HIV and hepatitis

Research Scientist & Biologist, Veterans Administration, Los Angeles, CA 1/2009 – 3/2013

Supervisor David O. Beenhouwer, MD, 310-***-****, *****@***.***, may be contacted.

Developed a novel ELISA to quantify leukotoxins in a large bank of staphylococcal cultures; Journal of Immunological Methods. 30: 1-5 (2010).

Second, discovered a novel mechanism vital to enhancing host-mediated immune response to the most common bacterial maladies, Staphylococcal infections; identifying a candidate cytotoxic bi-component system for therapeutic purposes. PLOS ONE 9: e89308, 1-11(2014).

Director Operations, Senior scientist, Chimeric Technologies, Inc., Los Angeles, CA 7/2002 – 12/2008

CEO Doug Levinson, 310-***-****, *******@**.***, may be contacted.

Led the development and optimization of blood agglutinating efficacy of an antibody as a diagnostic reagent using red blood cells from more than 2000 volunteers. Journal of Immunological Methods, 340: 1-10.

Project Manager & Research Immunologist, University of California, Los Angeles, CA 7/1997 – 6/2002

Supervisor Sherie L. Morrison, Ph.D, 310-***-****, *******@****.***, may be contacted.

Develop antibodies with novel effector functions. Clinical Immunology, 101: 21-31. Patent # 6,284,536.

Managed timelines for assays and product transfer.

Trained students and fellows in writing papers, and preparing and presenting at meetings.

Post-Doctoral Scholar, University of California, Los Angeles, CA 7/1992 – 6/1997

Developed technology to produce IgA and secretory IgA (a form found in human milk) in mammalian cells in large quantities for commercial purposes. PNAS. USA, 94, 6364. Patent # 6,300,104.

Software development related publication: Gurbaxani, B., Dela Cruz, L.L., Chintalacharuvu, K. R. and Morrison, S. L. (2006). Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life. Molecular Immunology, 43: 1462-1473.

EDUCATION: PhD, Immunology & Experimental Pathology, Case Western Reserve Univ., Cleveland OH

Contact this candidate